Delivery Order 75N93020D00006-75N93023F00001

Award Date 9/1/23
Potential Completion Date 8/31/25
Potential Value $2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,887,979.00 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company based in Rockville, Maryland. The contract is for "CONDUCT STUDY P215" under the Simian Vaccine Evaluation Units (SVEUS) major program. This delivery order is not associated with a set-aside program. Bioqual has been awarded multiple NIAID contracts, including a...
This is a federal contract award to Bioqual, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for "SIMIAN VACCINE EVALUATION UNITS". The contract has a ceiling value of $4,398,713.69 and an ultimate completion date of September 13, 2024. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which allows for task orders related to primate vaccine...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. as the prime contractor. The contract, valued at $544,999.84, is for the housing and maintenance of non-human primates in support of biomedical research. This award falls under Bioqual's existing Simian Vaccine Evaluation Units (SVEU) indefinite-delivery/indefinite-quantity (IDIQ) contract with NIAID, which...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. as the prime contractor. The contract, which has a ceiling value of $1,216,423.00, is for conducting a study related to the Simian Vaccine Evaluation Units (SVEUS) major program. It is a cost-plus-fixed-fee contract type issued under the SVEUS indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The ultimate completion date for the...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. as a prime contractor. The contract is part of the Simian Vaccine Evaluation Units vehicle, a 7-year indefinite-delivery contract that allows for task orders related to primate vaccine studies, care, and housing. The award has a ceiling value of $160,031.85 and is a Cost Plus Fixed Fee contract type. The contract does not have a set-aside designation....
This federal contract award supports the "Simian Vaccine Evaluation Units" program of the National Institute of Allergy and Infectious Diseases (NIAID). The prime contractor is Bioqual, Inc., a for-profit company that provides research facilities, scientists, and animal care personnel to support biomedical studies. The $2,181,693.43 award has a period of performance through August 2019 and is a delivery order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The...
This is a $608,420.77 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. for "SIMIAN VACCINE EVALUATION UNITS". The contract is a task order issued under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Bioqual, a for-profit organization, provides animal research support services including housing, care, and testing for...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Bioqual, Inc. The $543,520.80 contract is a delivery order under the Simian Vaccine Evaluation Units indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which supports primate vaccine studies, care, and housing over a seven-year period. The work to be performed under this award is related to Simian Vaccine Evaluation Units. There was no set-aside designation for...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price delivery order contract to Bioqual, Inc., a for-profit organization, for the housing and maintenance of non-human primates for NIAID's Vaccine Research Center (VRC). The contract, which has a potential value of $882,660.21, was awarded on September 26, 2018 and is set to be completed by September 27, 2019. This award is...
This is a $294,760.24 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. under the Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is for SIMIAN VACCINE EVALUATION UNITS and does not have a set-aside designation. Bioqual is a prime contractor that provides animal research services, including housing and caring for nonhuman primates,...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit organization, to conduct a study called "CONDUCT STUDY P221." The contract has a ceiling value of $1,999,460.00 and is a delivery order under the Simian Vaccine Evaluation Units (SVEU) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle held by NIAID. The contract has an ultimate completion date of August 31, 2025 and was awarded on September 1, 2023. This award does not have a set-aside designation.

Bioqual, Inc. is an experienced research services provider that supports biomedical research programs, including serving as a prime contractor for NIAID to conduct animal studies, provide laboratory analysis, and house and care for research animals. This specific award is likely related to NIAID's infectious disease research efforts, as Bioqual has supported NIAID's work in areas such as HIV cure research, immune system studies, and testing of radiation recovery compounds.

Generated 9/20/24, 9:03 AM